YorkBridge Wealth Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $284K | Sell |
1,027
-3
| -0.3% | -$831 | 0.07% | 202 |
|
|
2022
Q3 | $275K | Hold |
1,030
| – | – | 0.07% | 214 |
|
|
2022
Q2 | $210K | Sell |
1,030
-7
| -0.7% | -$1.43K | 0.05% | 263 |
|
|
2022
Q1 | $218K | Hold |
1,037
| – | – | 0.05% | 274 |
|
|
2021
Q4 | $249K | Sell |
1,037
-3
| -0.3% | -$720 | 0.06% | 252 |
|
|
2021
Q3 | $294K | Sell |
1,040
-8
| -0.8% | -$2.26K | 0.07% | 215 |
|
|
2021
Q2 | $363K | Sell |
1,048
-5
| -0.5% | -$1.73K | 0.09% | 171 |
|
|
2021
Q1 | $295K | Sell |
1,053
-149
| -12% | -$41.7K | 0.09% | 199 |
|
|
2020
Q4 | $294K | Sell |
1,202
-63
| -5% | -$15.4K | 0.1% | 150 |
|
|
2020
Q3 | $359K | Buy |
1,265
+11
| +0.9% | +$3.12K | 0.15% | 118 |
|
|
2020
Q2 | $336K | Sell |
1,254
-11
| -0.9% | -$2.95K | 0.15% | 119 |
|
|
2020
Q1 | $400K | Sell |
1,265
-513
| -29% | -$162K | 0.25% | 94 |
|
|
2019
Q4 | $528K | Sell |
1,778
-243
| -12% | -$72.2K | 0.24% | 98 |
|
|
2019
Q3 | $471K | Sell |
2,021
-96
| -5% | -$22.4K | 0.24% | 100 |
|
|
2019
Q2 | $495K | Sell |
2,117
-88
| -4% | -$20.6K | 0.22% | 95 |
|
|
2019
Q1 | $521K | Sell |
2,205
-46
| -2% | -$10.9K | 0.24% | 93 |
|
|
2018
Q4 | $677K | Sell |
2,251
-209
| -8% | -$62.9K | 0.36% | 71 |
|
|
2018
Q3 | $867K | Sell |
2,460
-86
| -3% | -$30.3K | 0.4% | 69 |
|
|
2018
Q2 | $739K | Sell |
2,546
-119
| -4% | -$34.5K | 0.32% | 75 |
|
|
2018
Q1 | $713K | Buy |
2,665
+18
| +0.7% | +$4.82K | 0.33% | 78 |
|
|
2017
Q4 | $869K | Sell |
2,647
-298
| -10% | -$97.8K | 0.42% | 65 |
|
|
2017
Q3 | $922K | Sell |
2,945
-50
| -2% | -$15.7K | 0.48% | 55 |
|
|
2017
Q2 | $816K | Buy |
2,995
+36
| +1% | +$9.81K | 0.43% | 61 |
|
|
2017
Q1 | $803K | Buy |
2,959
+155
| +6% | +$42.1K | 0.42% | 64 |
|
|
2016
Q4 | $856K | Buy |
+2,804
| New | +$856K | 0.51% | 55 |
|